U.S. Markets closed
  • S&P 500

    4,704.54
    +15.87 (+0.34%)
     
  • Dow 30

    35,870.95
    -60.10 (-0.17%)
     
  • Nasdaq

    15,993.71
    +72.14 (+0.45%)
     
  • Russell 2000

    2,363.59
    -13.42 (-0.56%)
     
  • Gold

    1,861.20
    -0.20 (-0.01%)
     
  • Silver

    24.88
    -0.02 (-0.08%)
     
  • EUR/USD

    1.1369
    -0.0006 (-0.0568%)
     
  • 10-Yr Bond

    1.5890
    -0.0150 (-0.94%)
     
  • Vix

    17.59
    +0.48 (+2.81%)
     
  • GBP/USD

    1.3497
    -0.0003 (-0.0216%)
     
  • USD/JPY

    114.3040
    +0.0520 (+0.0455%)
     
  • BTC-USD

    54,030.80
    -4,709.68 (-8.02%)
     
  • CMC Crypto 200

    1,402.14
    -65.80 (-4.48%)
     
  • FTSE 100

    7,255.96
    -35.24 (-0.48%)
     
  • Nikkei 225

    29,683.09
    +84.43 (+0.29%)
     

Analysts Have Mixed Reactions On Cintas Q1 Earnings

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • BofA analyst Gary Bisbee raised Cintas Corp's (NYSE: CTAS) price target to 0 (implying an upside of 4.7%) from 3 and maintained a Neutral rating on the shares after the company reported Q1 results.

  • Bisbee said that organic CC same-days revenue rose a "healthy" 8.6% year-over-year, as it continues to comp the year-over-year declines seen at the start of the pandemic.

  • Bisbee noted that margins rose a little more than expected, which along with a lower tax rate drove a "healthy" EPS beat.

  • Morgan Stanley analyst Toni Kaplan lowered the price target to $365 (implying a downside of 4.5%) from $368 and maintained an Equal-Weight rating on the shares.

  • Price action: CTAS shares are trading lower by 1.53% at $383.32 on the last check Thursday.

Latest Ratings for CTAS

Sep 2021

B of A Securities

Maintains

Neutral

Sep 2021

Morgan Stanley

Maintains

Equal-Weight

Sep 2021

Morgan Stanley

Maintains

Equal-Weight

View More Analyst Ratings for CTAS
View the Latest Analyst Ratings

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.